Imipramine in the treatment of panic disorder and its complications.
The recognition of the efficacy of imipramine for treating panic disorder and its complications has had major implications for clinical practice, diagnostic classification, theoretic understanding, and research strategies in the anxiety disorders. It has also resulted in benefit for a great number of affected individuals and promises to yield even greater relief of suffering as the findings become more widely disseminated.
D000379:Agoraphobia / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D001521:Behavior Therapy; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D005239:Fear / Q000187:drug effects*; D006801:Humans; D007099:Imipramine / Q000494:pharmacology / Q000627:therapeutic use*; D010200:Panic / Q000187:drug effects*; D012107:Research Design
D000929:Antidepressive Agents, Tricyclic; D007099:Imipramine